JNJoseph Nyandwi

Joseph Nyandwi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joseph Nyandwi has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic investigation of an Influenza A(H3N2) subclade K outbreak in a secondary school in Burundi, 2026

    by Néhémie Nzoyikorera, Leonard Schuele, David F. Nieuwenhuijse, Cassien Nduwimana, Armstrong Ndihokubwayo, Théogène Ihorimbere, Denis Niyomwungere, Hayley Cassidy, Marjan Boter, Alexis Niyomwungere, et al.

  • Open Access

    Community perceptions and health-seeking behaviour towards mpox during an outbreak in Burundi: a qualitative socio-ecological analysis

    by Néhémie Nzoyikorera, Emmanuelline Mukama, Jonas Ngendakumana, Ferdinand Nsengimana, Roger Ciza, Alain Tamba Yombouno, Josephine Bayigga, Ruben Kiggundu, Cathy Asiimwe Tabaro, Anatole Nkeshimana, et al.

  • Open Access

    Epidemiological characteristics and vaccination impact scenario modelling of concurrent Clade I mpox outbreaks in the Democratic Republic of the Congo and Burundi

    by Ruth McCabe, Edward Knock, Alba Halliday, Victoria M Cox, Daniela Olivera Mesa, Kieran Chopra, Brian Ajong, Jean-Claude Bizimana, Thierry Kalonji, Olivier Kamatari, et al.

    In 2024, mpox cases surged in the Democratic Republic of the Congo (DRC) with cross-border spread to Burundi. We developed a transmission-dynamic model calibrated against surveillance data to understand drivers in enzootic (Clade Ia) and non-enzootic (Clade Ib) areas, and the potential impact of vaccination. In non-enzootic areas we estimated that 58-84% of transmission occurred within sexual networks. MVA-BN vaccination of sex workers could have averted 91% (95% CrI 81%–98%) of infections in Sud Kivu (DRC) but only 35% (95% CrI 26%–47%) in Bujumbura (Burundi), due to later outbreak detection. In historically enzootic Equateur (DRC), ongoing zoonotic spillover best explained sustained incidence. There, pledged Lc18m8 vaccines could have averted 42% (95% CrI 40%–46%) of infections; prioritising children improved impact. Across all settings, doubling vaccine coverage by using a single dose of MVA-BN outperformed two-dose strategies. Timely detection and tailored vaccination strategies are critical to reducing mpox burden.


  • Open Access

    Identification of a Novel Plasmodium falciparum Kelch13 A676T Variant and high Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Cibitoke, Burundi

    by Tolulope Kayode, David Niyukuri, Aurel Holzschuh, Gustavo Da Silva, Tiffany Huwe, Anita Lerch, Joseph Nyandwi, Cristian Koepfli

    Antimalarial resistance, including reduced susceptibility to artemisinin-based combination therapies, is increasing in Africa. 157 P. falciparum isolates from Cibitoke, Burundi, were sequenced for ten resistance markers (including background loci associated with kelch13 -mediated artemisinin partial resistance) using Nanopore sequencing. Plasmepsin -2 and pfmdr1 copy number variations were assessed by digital PCR. No validated pfkelch13 mutations linked to artemisinin partial resistance were detected. A novel pfkelch13 mutation, A676T, was identified in one isolate, adjacent to the validated A675V mutation reported in neighboring East African countries. Mutant alleles were observed at several background loci previously implicated in artemisinin resistance in Southeast Asia, including pffd D193Y (7.0%), pfmdr2 I492V (31.8%), pfatg18 T38I (3.2%), and pfarps10 V127M/D128H (2.6%), while pfpx1 (C1484F) and pfmdr2 (T484I) remained wild type. However, their functional role in Africa remains uncertain. Sulfadoxine-pyrimethamine (SP) resistance was widespread. In single-clone infections, the quintuple pfdhfr/pfdhps haplotype predominated (59.6%). Chloroquine resistance–associated pfcrt IET triple mutant haplotypes at codons 74-76 were detected in 94.3% of isolates. pfmdr1 haplotypes defined by codons 86, 184, and 1246 were dominated by NYD (56.3%) and NFD (40.4%). No pfpm2 duplications were observed, while pfmdr1 copy number amplification was rare (1.8%). These findings reveal a high prevalence of mutations associated with SP resistance, posing a threat to the efficacy of intermittent preventive treatment in pregnancy and seasonal malaria chemoprevention in Burundi. The identification of the pfkelch13 A676T variant highlights the importance of continued genomic surveillance. However, the role of this mutation in artemisinin resistance remains to be determined.

  • Open Access

    Performance of highly sensitive and conventional rapid diagnostic tests for clinical and subclinical Plasmodium falciparum infections, and hrp2/3 deletion status in Burundi

    by David Niyukuri, Denis Sinzinkayo, Emma V. Troth, Colins O. Oduma, Mediatrice Barengayabo, Mireille Ndereyimana, Aurel Holzschuh, Claudia A. Vera-Arias, Yilekal Gebre, Kingsley Badu, et al.

    Rapid diagnostic tests (RDTs) are a key tool for the diagnosis of malaria infections among clinical and subclinical individuals. Low-density infections, and deletions of the P. falciparum hrp2/3 genes (encoding the HRP2 and HRP3 proteins detected by many RDTs) present challenges for RDT-based diagnosis. The novel Rapigen Biocredit three-band Plasmodium falciparum HRP2/LDH RDT was evaluated among 444 clinical and 468 subclinical individuals in a high transmission setting in Burundi. Results were compared to the AccessBio CareStart HRP2 RDT, and qPCR with a sensitivity of P = 0.048). Specificity of the Biocredit was 82.4% compared to 96.2% for CareStart. Among subclinical infections, sensitivity was 72.3% (162/224) compared to 58.5% (131/224) for CareStart (P = 0.003), and reached 88.3% (53/60) in children hrp2 and 2/366 hrp3 deletions were observed. In conclusion, the novel RDT showed improved sensitivity for the diagnosis of P. falciparum.


  • Open Access

    Pulmonary embolism in Bujumbura

    by Eugène Ndirahisha, Thierry Sibomana, Joseph Nyandwi, Ramadhan Nyandwi, Sébastien Manirakiza, Patrice Barasukana, Hermenegilde Nahayo, Elysée Baransaka, Ньяндви Дж., Ньяндви Р., et al.

    Relevance . Pulmonary embolism constitutes a diagnostic and therapeutic emergency. In Africa, data are still difficult to obtain. Thus, the objectives of this work is to describe epidemiological, clinical, therapeutic aspects and short-term outcomes of pulmonary embolism confirmed by thoracic angioscan at Kira hospital in Bujumbura, the biggest city of Burundi with population about 375 000. Patients and Methods . This was a descriptive study of 18 patients who had a pulmonary embolism confirmed by thoracic angioscan in Bujumbura from January 1st, 2015 to December 31st, 2018. We included in our study any patient with pulmonary embolism consenting to participate and processing personal data after some clarified explanations in accordance with the World Medical Associations Declaration of Helsinki. For each registered patient, we collected socio-demographic, past history of cardiac disease and factors risk, clinical, echocardiographic and scannographic findings with Wells score. Variables were presented as means and percentages. Results and Discussion. The average age was 53.5 12.3 years with a sex ratio of 1.25 in favor of women. The modal class was the 50 to 59 age group (33.3%). The clinical probability pre-test by simplified Wells score was high in 66.6% and medium in 33.3% of cases. A history of venous thromboembolic disease was the most common risk factor. Dyspnea was the most reason of consultation with 94.4% of cases. One patient died (5.6%) during hospitalization. Six months after discharge from the hospital, we recorded 3 cases (16.7%) of death, 6 cases (33.3%) of pulmonary heart, 3 cases (16.7%) of recurrent pulmonary embolism and one case of vitamin K antagonist overdose with minor bleeding. Conclusion. Pulmonary embolism is common in relatively young population with a predominance of females and chronic no communicable diseases as risk factors. Examination of a patient with an angioscanner is a sensitive and specific clinical study of pulmonary embolism. The outcome is favorable under appropriate treatment in short term.

  • Open Access

    Cardiovascular risk factors in rural areas: case of the Mabayi health district hospital in Burundi

    by Eugène Ndirahisha, Patrice Barasukana, Joseph Nyandwi, Sébastien Manirakiza, Rhamadhan Nyandwi, Elysée Baransaka, Ньяндви Дж., Ньяндви Р.

    Relevance . Noncommunicable diseases are a serious public health problem due to their high incidence and mortality rate. Globally, noncommunicable diseases cause 41 million deaths every year, accounting for 71% of the total number of deaths. Cardiovascular diseases, accounting for 44% of all noncommunicable diseases, are the leading causes of death. Early identification of the main risk factors for cardiovascular diseases and treatment of associated diseases are a prerequisite for maintaining the health of the population. Objective: To identify the main risk factors for cardiovascular disease in patients living in rural areas of the mountainous region and attending the Mabayi District Hospital in Burundi. Patients and Methods . An open-label retrospective study conducted at the Mabayi District Hospital in Burundi from January 2014 to December 2017. The study included patients whose medical examination revealed at least one risk factor for cardiovascular diseases. The study was approved by the ethics committee of the Kamenge University Hospital and the Faculty of Medicine of the University of Burundi. Data analysis was carried out using Microsoft Word 2007 and Epi-Info TM 7.2.1.0 software. Results and Discussion . Among the 20 297 examined patients, the average age was 50 16.7 years, the extreme values were 14 and 101 years. Male patients accounted for 51.1%. 903 patients (4.5%) had at least one risk factor. The main risk factors were high blood pressure (52.6%), diabetes (42.0%) and alcohol abuse (27.4%). Conclusion . Residents of rural areas of the mountainous region of Burundi have a high frequency of risk factors for cardiovascular diseases, which must be taken into account when organizing medical and preventive measures to prevent cardiovascular diseases.


  • Open Access

    Management of Rheumatic Heart Diseases in Burundi

    by Eugene Ndirahisha, E Baransaka, J Nyandwi, H Bukuru, C Muserebanyi, M Nimburanira, R Nyandwi

    Background: The surgical management of rheumatic heart disease (RHD) in Burundi is almost impossible because of the absence of the technical plateau. Aim: To describe the therapeutic and evolutionary aspects of RHD in Burundi. Patients and methods: This is a retrospective and analytical study of patients' records in surgical indication and/or operated for RHD by facilitation of “Maison du Bon Samaritain du Burundi (MBSB)” from February 2015 to February 2017. Results: Among 89 patients consulting for RHD, 45 (50.56%) were operated. The average age of the patients was 25 years. Females predominated with 64.04% of cases. The age of most of patients was between 4 and 40 years with 74 cases (83.14%). All patients had been received at the heart failure stage including 83 (93.25%) at stage III or IV according to the New York Heart Association (NYHA) classification. The ejection fraction was ≤ 50% in 61 patients (68.53%). Pulmonary arterial hypertension was recorded in 79 patients (88.76%). On chest X-ray, cardiomegaly was found in 85 patients (95.50%). Electrical abnormalities were dominated by dilatation of the left atrium in 48 cases (53.93%). Isolated valvular lesions were the most numerous with 67 cases (75.28%). The operative management was mainly valvular replacement (93.47%) with an operative success of 100% six months after the intervention. Conclusion: The diagnosis of RHD was late. Young people were more vulnerable. The postoperative prognosis at six months was good.

  • Manifestations ophtalmologiques de la granulomatose de Wegener. Revue de la littérature à propos d’une observation

    by Richard Montagnac, Joseph Nyandwi, Gérard Loiselet, Jean Pradel, Francis Schillinger

    Wegener's granulomatosis mainly affects the upper respiratory tract, the lungs and the kidneys but many other organs and tissues may be affected, as well including any eye structures. Ocular and orbital structures involvement is frequently encountered, sometimes inaugural, with or without obvious systemic manifestations, sometimes leading to visual loss. The most frequent ophthalmic lesions are inflammatory orbital disease, (necrotising) scleritis with or without keratopathy, episcleritis, conjunctivitis and even conjunctival ulcer, nasolacrimal ducts obstruction, uveitis, retinal vasculitis and even central retinal vascular occlusion, optic neuritis. These ocular lesions result either from extensive granulomatous inflammation or from focal vasculitis. These complications need to be recognized as soon as possible so that an early diagnosis may allow the appropriate treatment meant to keep both visual and even general prognosis.